You have 9 free searches left this month | for more free features.

Condition

Hidradenitis Suppurativa (1)

Myelofibrosis (1)

Renal Transplant Rejection (1)

Warm Antibody Autoimmune Hemolytic Anemia (1)

Overall Status

Recruiting (3)

Completed (1)

Sign in for free

Phase

phase 2 (3)

phase 1/phase 2 (1)

Sponsor

Holdsworth House Medical Practice (1)

Imperial College London (1)

Rigel Pharmaceuticals (1)

Washington University School of Medicine (1)

Collaborator

Rigel Pharmaceuticals (2)

Intervention

fostamatinib (3)

fostamatinib 150 mg bid (1)

ruxolitinib (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (4)

Tavalisse

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

Recruiting

Myelofibrosis

Saint Louis, Missouri

Washington University School of Medicine

Oct 26, 2022

Hidradenitis Suppurativa Trial in Sydney (Fostamatinib)

Recruiting

Hidradenitis Suppurativa

Fostamatinib

Sydney, New South Wales, Australia

Holdsworth House Medical Practice

Mar 15, 2022

Renal Transplant Rejection Trial in London (Fostamatinib)

Recruiting

Renal Transplant Rejection

Fostamatinib

London, United Kingdom

Imperial College NHS Healthcare Trust

Oct 1, 2021

Warm Antibody Autoimmune Hemolytic Anemia Trial in Canada, United States (Fostamatinib 150 mg bid)

Completed

Warm Antibody Autoimmune Hemolytic Anemia

Fostamatinib 150 mg bid

Gilbert, Arizona
+35 more

Jul 19, 2021